Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYH1 MYH2 MYH4 ATRX NSF MYO9A ABCA13 YTHDC2 BTAF1 IDE DNAH7 ABCA10 MYO5C MSH6 DNAH17 DDX43 AQR	5.02e-06	614	153	17	GO:0140657
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYO9A MYO5C	1.01e-05	38	153	5	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYO9A DNAH7 MYO5C DNAH17	3.50e-05	118	153	7	GO:0003774
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 MYH4 MYO9A ESPNL FMNL2 MYO5C FMNL3 ADSS1	6.54e-05	227	153	9	GO:0051015
GeneOntologyMolecularFunction	SUMO binding	ZCCHC18 ZCCHC12 USP25	3.91e-04	19	153	3	GO:0032183
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH4 MYO5C PLCB1 TRPV6 AKT1 UNC13A	4.05e-04	230	153	8	GO:0005516
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	ATRX DIS3L YTHDC2 BTAF1 DUS2 MSH6 ERI3 RNASET2 PCIF1 XRN1 DDX43 TRMT5 GEN1 AQR	4.51e-04	645	153	14	GO:0140640
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain phosphoserine binding	SCAF4 PCIF1	5.75e-04	5	153	2	GO:1990269
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH4 ATRX NSF ABCA13 YTHDC2 BTAF1 IDE DNAH7 ABCA10 DDX43 AQR	6.06e-04	441	153	11	GO:0016887
GeneOntologyMolecularFunction	3'-5' RNA helicase activity	YTHDC2 AQR	8.57e-04	6	153	2	GO:0034458
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MYH4 RRAS2 ATRX NSF ABCA13 YTHDC2 BTAF1 IDE DNAH7 ABCA10 TUBB6 TUBB4A DDX43 AQR ADSS1	9.21e-04	775	153	15	GO:0017111
GeneOntologyMolecularFunction	modification-dependent protein binding	ATRX L3MBTL2 CGAS IDE MSH6 PSME4 PLCG2	1.07e-03	206	153	7	GO:0140030
GeneOntologyMolecularFunction	actin binding	MYH1 MYH2 MYH4 TRPM7 MYO9A ESPNL FMNL2 MYO5C FMNL3 DST ADSS1	1.19e-03	479	153	11	GO:0003779
GeneOntologyMolecularFunction	dynein light intermediate chain binding	RILPL1 DNAH7 DNAH17	1.26e-03	28	153	3	GO:0051959
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYO9A MYO5C	6.73e-05	59	151	5	GO:0016459
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4	1.93e-04	16	151	3	GO:0005859
Domain	PNMA	ZCCHC18 ZCCHC12 PNMA5 PNMA2	1.30e-06	11	151	4	IPR026523
Domain	PNMA	ZCCHC18 ZCCHC12 PNMA5 PNMA2	1.30e-06	11	151	4	PF14893
Domain	P-loop_NTPase	MYH1 MYH2 MYH4 RRAS2 SAMD9 ATRX NSF MYO9A ABCA13 YTHDC2 BTAF1 CMSS1 DNAH7 ABCA10 MYO5C MSH6 HS2ST1 DDX43 AQR NLRP13 ADSS1	4.79e-06	848	151	21	IPR027417
Domain	Myosin_N	MYH1 MYH2 MYH4 MYO5C	5.23e-06	15	151	4	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYO5C	5.23e-06	15	151	4	IPR004009
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYO9A MYO5C	1.31e-05	38	151	5	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYO9A MYO5C	1.31e-05	38	151	5	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYO9A MYO5C	1.31e-05	38	151	5	PF00063
Domain	MYSc	MYH1 MYH2 MYH4 MYO9A MYO5C	1.31e-05	38	151	5	SM00242
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYO5C	1.45e-05	19	151	4	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYO5C	1.45e-05	19	151	4	4.10.270.10
Domain	ARM-type_fold	PPP4R1 GPRASP1 APC ARFGEF2 BTAF1 FMNL2 FMNL3 SF3B1 PSME4 XPO5 AOPEP UTP20	2.07e-05	339	151	12	IPR016024
Domain	Peptidase_M16_M	NRDC IDE	6.49e-05	2	151	2	PF16187
Domain	PIEZO	PIEZO1 PIEZO2	6.49e-05	2	151	2	PF15917
Domain	Peptidase_M16_M	NRDC IDE	6.49e-05	2	151	2	IPR032632
Domain	Piezo	PIEZO1 PIEZO2	6.49e-05	2	151	2	IPR027272
Domain	Piezo_RRas_bdg	PIEZO1 PIEZO2	6.49e-05	2	151	2	PF12166
Domain	Piezo_RRas-bd_dom	PIEZO1 PIEZO2	6.49e-05	2	151	2	IPR031334
Domain	Piezo_dom	PIEZO1 PIEZO2	6.49e-05	2	151	2	IPR031805
Domain	-	PPP4R1 GPRASP1 APC ARFGEF2 BTAF1 SF3B1 PSME4 XPO5 UTP20	8.26e-05	222	151	9	1.25.10.10
Domain	HEAT_REPEAT	PPP4R1 BTAF1 SF3B1 PSME4 UTP20	2.56e-04	70	151	5	PS50077
Domain	IQ	MYH1 MYH2 MYH4 MYO9A MYO5C	2.74e-04	71	151	5	PF00612
Domain	ARM-like	PPP4R1 GPRASP1 APC ARFGEF2 BTAF1 SF3B1 PSME4 XPO5 UTP20	3.57e-04	270	151	9	IPR011989
Domain	Myosin_tail_1	MYH1 MYH2 MYH4	3.87e-04	18	151	3	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4	3.87e-04	18	151	3	IPR002928
Domain	IQ	MYH1 MYH2 MYH4 MYO9A MYO5C	5.05e-04	81	151	5	SM00015
Domain	HEAT	PPP4R1 BTAF1 SF3B1 UTP20	6.06e-04	48	151	4	PF02985
Domain	DUF4371	ZMYM1 ZMYM6	6.39e-04	5	151	2	IPR025398
Domain	DUF4371	ZMYM1 ZMYM6	6.39e-04	5	151	2	PF14291
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYO9A MYO5C	8.18e-04	90	151	5	IPR000048
Domain	IQ	MYH1 MYH2 MYH4 MYO9A MYO5C	9.49e-04	93	151	5	PS50096
Domain	-	RRAS2 SAMD9 ATRX NSF ABCA13 YTHDC2 BTAF1 CMSS1 DNAH7 ABCA10 MSH6 HS2ST1 DDX43 AQR NLRP13	1.07e-03	746	151	15	3.40.50.300
Domain	HEAT	PPP4R1 BTAF1 SF3B1 UTP20	1.24e-03	58	151	4	IPR000357
Domain	Pept_M16_Zn_BS	NRDC IDE	1.33e-03	7	151	2	IPR001431
Domain	Pept_M16_dom	NRDC IDE	1.33e-03	7	151	2	IPR011237
Domain	Metalloenz_LuxS/M16	NRDC IDE	1.33e-03	7	151	2	IPR011249
Domain	Peptidase_M16	NRDC IDE	1.33e-03	7	151	2	PF00675
Domain	Znf_MYM	ZMYM1 ZMYM6	1.33e-03	7	151	2	IPR010507
Domain	Peptidase_M16_C	NRDC IDE	1.33e-03	7	151	2	IPR007863
Domain	Peptidase_M16_C	NRDC IDE	1.33e-03	7	151	2	PF05193
Domain	Pept_M16_N	NRDC IDE	1.33e-03	7	151	2	IPR011765
Domain	-	NRDC IDE	1.33e-03	7	151	2	3.30.830.10
Domain	INSULINASE	NRDC IDE	1.33e-03	7	151	2	PS00143
Domain	zf-FCS	ZMYM1 ZMYM6	1.33e-03	7	151	2	PF06467
Domain	TRASH_dom	ZMYM1 ZMYM6	1.76e-03	8	151	2	IPR011017
Domain	TRASH	ZMYM1 ZMYM6	1.76e-03	8	151	2	SM00746
Domain	Drf_GBD	FMNL2 FMNL3	2.25e-03	9	151	2	PF06371
Domain	Drf_FH3	FMNL2 FMNL3	2.25e-03	9	151	2	PF06367
Domain	FH3_dom	FMNL2 FMNL3	2.25e-03	9	151	2	IPR010472
Domain	GTPase-bd	FMNL2 FMNL3	2.25e-03	9	151	2	IPR010473
Domain	Drf_FH3	FMNL2 FMNL3	2.25e-03	9	151	2	SM01139
Domain	Drf_GBD	FMNL2 FMNL3	2.25e-03	9	151	2	SM01140
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PPP4R1 SAMD9 ATRX NRDC APC YTHDC2 BTAF1 ECE1 TUBB6 TGM2 FREM2 DST PSME4 TBK1 XRN1 MTR AQR MAN1B1	7.64e-10	650	154	18	38777146
Pubmed	Direct evidence for the action of phosphatidylinositol (3,4,5)-trisphosphate-mediated signal transduction in the 2-cell mouse embryo.	PLCB1 AKT1 AKT2 PLCG2	1.28e-08	7	154	4	17634444
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CFAP47 MYH1 MYH4 PCDHB12 NTMT1 AGPS FMNL2 MSH6 FREM2 LOXHD1 DST TBK1 PCIF1 PKHD1 UTP20 PLXNB3 PSMG4	3.34e-08	736	154	17	29676528
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	GPRASP1 MYH1 MYH2 MYH4	4.58e-08	9	154	4	31960486
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRIM46 RABEP2 GPRASP1 WDR7 NSF APC ARHGAP39 BCL9 PEX5L TUBB6 ZNF263 SF3B1 DST GPR158 KIAA1217 TBK1 PLCB1 NEURL4 UNC13A	5.97e-08	963	154	19	28671696
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 PPP4R1 GPRASP1 ZCCHC12 ATRX TRPM7 DIS3L USP25 APC ARFGEF2 RILPL1 FMNL2 TUBB4A SF3B1 DST APPL2 SACS GLUD1 PNMA2 PDZD8 GEN1 PLXNB3	6.04e-08	1285	154	22	35914814
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	8.51e-08	3	154	3	26059207
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RRAS2 L3MBTL2 CENPC MYO9A CGAS CASP8 AGPS CMSS1 ERLIN1 TUBB6 TGM2 MSH6 GTF2H1 SF3B1 DST PSME4 XRN1 UTP20 PYGL DDX43 PLCG2 AQR	1.47e-07	1353	154	22	29467282
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH4 ARFGEF2 BTAF1 MYO5C MSH6 XPO5 XRN1 UTP20 NEURL4	3.22e-07	202	154	9	33005030
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	3.39e-07	4	154	3	11029314
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	3.39e-07	4	154	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	3.39e-07	4	154	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	3.39e-07	4	154	3	11023856
Pubmed	Regulation of the Ca(2+) channel TRPV6 by the kinases SGK1, PKB/Akt, and PIKfyve.	PIKFYVE TRPV6 AKT1	3.39e-07	4	154	3	20041238
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4	8.46e-07	5	154	3	3829126
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4	8.46e-07	5	154	3	12919077
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	8.46e-07	5	154	3	30737693
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4	8.46e-07	5	154	3	6196357
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4	1.69e-06	6	154	3	1728586
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	1.69e-06	6	154	3	20417199
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4	1.69e-06	6	154	3	10077619
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	1.69e-06	6	154	3	17559643
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4	1.69e-06	6	154	3	10588881
Pubmed	Gene expression analysis of the embryonic subplate.	ZCCHC18 RRAS2 ZCCHC12 MYO9A CASP8 IDE CITED2 LRRN3	2.85e-06	196	154	8	21862448
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4	2.94e-06	7	154	3	35210422
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4	2.94e-06	7	154	3	29758057
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4	2.94e-06	7	154	3	16819597
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RRAS2 NSF YTHDC2 BTAF1 AGPS ERLIN1 SCAF4 MYO5C TUBB6 SF3B1 DST SACS TBK1 GLUD1 UTP20 NEURL4 AQR	3.26e-06	1024	154	17	24711643
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	4.69e-06	8	154	3	33667029
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4	4.69e-06	8	154	3	14667415
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4	4.69e-06	8	154	3	26993635
Pubmed	Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts.	APPL2 AKT1 AKT2	4.69e-06	8	154	3	20040596
Pubmed	Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration.	FMNL2 FMNL3 PDZD8 ZMYM6	8.05e-06	29	154	4	21834987
Pubmed	Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.	MYH1 MYH2 MYH4 AKT1	1.06e-05	31	154	4	30081710
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	GPRASP1 MYH2 MYH4 SUPT3H NRDC NSF USP25 APC YTHDC2 CMSS1 TBK1 PYGL SRPX NEURL4 ZMYM6 AQR	1.08e-05	1005	154	16	19615732
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SUPT3H ATRX NSF PIEZO1 APC YTHDC2 ARHGAP39 CMSS1 ERLIN1 SCAF4 TUBB6 MSH6 GTF2H1 DST APPL2 XRN1 UTP20 INTS9 AQR MAN1B1	1.10e-05	1497	154	20	31527615
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	PPP4R1 ATRX MYO9A APC PIKFYVE PIAS4 TUBB4A ALDH1A2 KIAA1217 TBK1 MTR ZMYM6	1.32e-05	588	154	12	38580884
Pubmed	Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.	TRPC1 AKT1 AKT2	1.37e-05	11	154	3	23077641
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH1 MYH2 MYH4	1.37e-05	11	154	3	18310078
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4	1.37e-05	11	154	3	8136524
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH1 MYH2 MYH4	1.37e-05	11	154	3	16024798
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4	1.37e-05	11	154	3	38303699
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH1 MYH2 MYH4	1.37e-05	11	154	3	29168801
Pubmed	Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development.	MYH1 MYH2 MYH4 AKT1	1.37e-05	33	154	4	32094117
Pubmed	Appl1 is dispensable for Akt signaling in vivo and mouse T-cell development.	APPL2 AKT1 AKT2	1.82e-05	12	154	3	20665729
Pubmed	Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.	AKT1 AKT2	1.95e-05	2	154	2	27878243
Pubmed	BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.	AKT1 AKT2	1.95e-05	2	154	2	27699769
Pubmed	Identification of proteins that interact with murine cytomegalovirus early protein M112-113 in brain.	ZCCHC18 ZCCHC12	1.95e-05	2	154	2	22340173
Pubmed	Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.	AKT1 AKT2	1.95e-05	2	154	2	31252679
Pubmed	Myosin heavy chains IIa and IId are functionally distinct in the mouse.	MYH1 MYH2	1.95e-05	2	154	2	9585413
Pubmed	Akt1 is critical for acute inflammation and histamine-mediated vascular leakage.	AKT1 AKT2	1.95e-05	2	154	2	19622728
Pubmed	Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients.	AKT1 AKT2	1.95e-05	2	154	2	28271235
Pubmed	[Feeling the pressure? Identification of two proteins activated by mechanical forces].	PIEZO1 PIEZO2	1.95e-05	2	154	2	21299953
Pubmed	Role of Akt in cardiac growth and metabolism.	AKT1 AKT2	1.95e-05	2	154	2	17019809
Pubmed	Repression of E1AF transcriptional activity by sumoylation and PIASy.	ETV4 PIAS4	1.95e-05	2	154	2	17585876
Pubmed	Piezo1 channel causes lens sclerosis via transglutaminase 2 activation.	PIEZO1 TGM2	1.95e-05	2	154	2	37951336
Pubmed	Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development.	PIEZO1 PIEZO2	1.95e-05	2	154	2	38395992
Pubmed	Knockout of Akt1/2 suppresses the metastasis of human prostate cancer cells CWR22rv1 in vitro and in vivo.	AKT1 AKT2	1.95e-05	2	154	2	33377281
Pubmed	Differential expression of PIEZO1 and PIEZO2 mechanosensitive channels in ocular tissues implicates diverse functional roles.	PIEZO1 PIEZO2	1.95e-05	2	154	2	37820892
Pubmed	Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin.	AKT1 AKT2	1.95e-05	2	154	2	9620559
Pubmed	Mechanisms of mechanotransduction and physiological roles of PIEZO channels.	PIEZO1 PIEZO2	1.95e-05	2	154	2	39251883
Pubmed	Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts.	AKT1 AKT2	1.95e-05	2	154	2	11861503
Pubmed	Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation.	AKT1 AKT2	1.95e-05	2	154	2	12808085
Pubmed	Analysis of mouse conceptuses with uniparental duplication/deficiency for distal chromosome 12: comparison with chromosome 12 uniparental disomy and implications for genomic imprinting.	MYH1 MYH2	1.95e-05	2	154	2	16575183
Pubmed	Immunolocalization of the mechanogated ion channels PIEZO1 and PIEZO2 in human and mouse dental pulp and periodontal ligament.	PIEZO1 PIEZO2	1.95e-05	2	154	2	37975162
Pubmed	Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes.	AKT1 AKT2	1.95e-05	2	154	2	15010337
Pubmed	Reducing Akt2 in retinal pigment epithelial cells causes a compensatory increase in Akt1 and attenuates diabetic retinopathy.	AKT1 AKT2	1.95e-05	2	154	2	36229454
Pubmed	Akt2 regulates cardiac metabolism and cardiomyocyte survival.	AKT1 AKT2	1.95e-05	2	154	2	16950770
Pubmed	Akt isoforms differentially regulate neutrophil functions.	AKT1 AKT2	1.95e-05	2	154	2	20332370
Pubmed	Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels.	PIEZO1 PIEZO2	1.95e-05	2	154	2	28636944
Pubmed	Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.	AKT1 AKT2	1.95e-05	2	154	2	3037531
Pubmed	High-intensity muscle contraction-mediated increases in Akt1 and Akt2 phosphorylation do not contribute to mTORC1 activation and muscle protein synthesis.	AKT1 AKT2	1.95e-05	2	154	2	32078465
Pubmed	Defining Akt actions in muscle differentiation.	AKT1 AKT2	1.95e-05	2	154	2	23076793
Pubmed	Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.	AKT1 AKT2	1.95e-05	2	154	2	19110052
Pubmed	Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.	AKT1 AKT2	1.95e-05	2	154	2	23919516
Pubmed	Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors.	AKT1 AKT2	1.95e-05	2	154	2	17804734
Pubmed	Lack of AKT in adipocytes causes severe lipodystrophy.	AKT1 AKT2	1.95e-05	2	154	2	27408773
Pubmed	Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation.	AKT1 AKT2	1.95e-05	2	154	2	17141631
Pubmed	PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.	AKT1 AKT2	1.95e-05	2	154	2	31781306
Pubmed	Piezo channels: from structure to function.	PIEZO1 PIEZO2	1.95e-05	2	154	2	25037583
Pubmed	Growth and muscle defects in mice lacking adult myosin heavy chain genes.	MYH1 MYH4	1.95e-05	2	154	2	9382868
Pubmed	Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.	MYH1 MYH4	1.95e-05	2	154	2	11150240
Pubmed	Myosin heavy chain composition of the human genioglossus muscle.	MYH1 MYH2	1.95e-05	2	154	2	22337492
Pubmed	A strategy to identify protein-N-myristoylation-dependent phosphorylation reactions of cellular proteins by using Phos-tag SDS-PAGE.	FMNL2 FMNL3	1.95e-05	2	154	2	31751425
Pubmed	Akt-1 and Akt-2 Differentially Regulate the Development of Experimental Autoimmune Encephalomyelitis by Controlling Proliferation of Thymus-Derived Regulatory T Cells.	AKT1 AKT2	1.95e-05	2	154	2	30692211
Pubmed	Distinct actions of akt1 on skeletal architecture and function.	AKT1 AKT2	1.95e-05	2	154	2	24663486
Pubmed	rac regulates its effector phospholipase Cgamma2 through interaction with a split pleckstrin homology domain.	AKT1 PLCG2	1.95e-05	2	154	2	18728011
Pubmed	Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.	AKT1 AKT2	1.95e-05	2	154	2	19491266
Pubmed	Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation.	AKT1 AKT2	1.95e-05	2	154	2	17609365
Pubmed	Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion.	AKT1 AKT2	1.95e-05	2	154	2	17825284
Pubmed	Depletion of Akt1 and Akt2 Impairs the Repair of Radiation-Induced DNA Double Strand Breaks via Homologous Recombination.	AKT1 AKT2	1.95e-05	2	154	2	31847370
Pubmed	Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.	AKT1 AKT2	1.95e-05	2	154	2	26654940
Pubmed	The role of PIEZO ion channels in the musculoskeletal system.	PIEZO1 PIEZO2	1.95e-05	2	154	2	36717101
Pubmed	Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions.	AKT1 AKT2	1.95e-05	2	154	2	16923802
Pubmed	Role of AMPK and Akt in triple negative breast cancer lung colonization.	AKT1 AKT2	1.95e-05	2	154	2	33839456
Pubmed	Akt1 and Akt2: differentiating the aktion.	AKT1 AKT2	1.95e-05	2	154	2	21432781
Pubmed	Molecular alterations in AKT and its protein activation in human lung carcinomas.	AKT1 AKT2	1.95e-05	2	154	2	22748472
Pubmed	Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner.	AKT1 AKT2	1.95e-05	2	154	2	17045205
Pubmed	Different pathways regulate expression of the skeletal myosin heavy chain genes.	MYH1 MYH2	1.95e-05	2	154	2	11551968
Pubmed	A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel.	PIEZO1 PIEZO2	1.95e-05	2	154	2	32142647
GeneFamily	Paraneoplastic Ma antigens	ZCCHC18 ZCCHC12 PNMA5 PNMA2	2.50e-07	11	97	4	671
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4	6.50e-05	15	97	3	1098
GeneFamily	Zinc fingers MYM-type	ZMYM1 ZMYM6	4.21e-04	6	97	2	86
GeneFamily	Transient receptor potential cation channels	TRPM7 TRPC1 TRPV6	4.45e-04	28	97	3	249
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA10	2.49e-03	14	97	2	805
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	RRAS2 SAMD9 ATRX APC ARFGEF2 BTAF1 AGPS CMSS1 ERLIN1 TGM2 MSH6 SF3B1 GPR158 PNMA2 XRN1 PLCB1 TRMT5	1.27e-06	721	154	17	M10237
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	AKAP6 TRIM46 GPRASP1 ZCCHC12 SLC16A9 ATRX APC PEX5L FMNL2 CITED2 FSIP2 LRRN3 FAT2 PIEZO2 GPR158 CSAD PNMA2 CATSPERG SVOP UNC13A	8.03e-06	1106	154	20	M39071
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TIGD7 MYO9A ABCA13 TRPC1 BCO1 FSIP2 DNAH17 AKT2	5.76e-08	151	154	8	16fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZCCHC12 ETV4 PEX5L ALDH1A2 PIEZO2 GPR158 PNMA2 UNC13A	2.63e-07	184	154	8	e0e5a553fb8c0947679634396d20c2ca8455b932
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZCCHC12 ETV4 PEX5L ALDH1A2 PIEZO2 GPR158 PNMA2 UNC13A	2.63e-07	184	154	8	c3b848e1438a84b3fac8a4e40f3db478cc84d970
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	MAOB OLFML3 ADAMTS12 CITED2 TGM2 LRRN3 PIEZO2 DST	3.36e-07	190	154	8	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MAOB ABCA10 OLFML3 ADAMTS12 ALDH1A2 PIEZO2 DST SRPX	4.96e-07	200	154	8	d769723f8fcb37d9b86589e0c41c1d7f16393cfe
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 ATRX CENPC CASP8 BTAF1 SF3B1 XRN1 PLCG2	4.96e-07	200	154	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 GPRASP1 ATRX TRPM7 MYO9A PSME4 XRN1	2.72e-06	176	154	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 EML6 DNAH7 ALDH1A2 PKHD1 AKT2	3.65e-06	184	154	7	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TRIM46 GPRASP1 NSF PAK6 GPR158 SVOP UNC13A	4.51e-06	190	154	7	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 EML6 DNAH7 ALDH1A2 PKHD1 PLCB1	4.67e-06	191	154	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Posterior_cortex-Neuronal\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GPRASP1 ATRX NSF MYO9A PAK6 SVOP UNC13A	5.00e-06	193	154	7	b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	OLFML3 ADAMTS12 CITED2 IL1RAPL1 ALDH1A2 PIEZO2 DST	5.17e-06	194	154	7	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAOB OLFML3 CITED2 TGM2 LRRN3 PIEZO2 DST	5.53e-06	196	154	7	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAOB OLFML3 CITED2 TGM2 LRRN3 PIEZO2 DST	5.53e-06	196	154	7	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PEX5L IL1RAPL1 TUBB4A AOPEP DNAH17 PLXNB3 SEC14L5	6.31e-06	200	154	7	829978708463a7459fe1041bd90196775bc4b531
ToppCell	PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP47 BPIFB1 FETUB ALDH1A2 PNMA2 PKHD1	1.15e-05	145	154	6	9b69bfdbf91ef197b4c483617aa67498d9d2cd79
ToppCell	PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP47 BPIFB1 FETUB ALDH1A2 PNMA2 PKHD1	1.15e-05	145	154	6	31af9fce1dcd7e8ae1604476598e099232017ee9
ToppCell	PND28-Epithelial-Epithelial_Airway-Neurosecretory\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP47 BPIFB1 FETUB ALDH1A2 PNMA2 PKHD1	1.15e-05	145	154	6	76f0cde9acdc3ad5948c007dccf312665972c9e6
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3\|E16.5-samps / Age Group, Lineage, Cell class and subclass	YTHDC2 TUBB6 LRRN3 PNMA2 ZMYM1 ZMYM6	1.34e-05	149	154	6	651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	SLC16A9 ESPNL PIEZO2 DST KIAA1217 PNMA2	1.74e-05	156	154	6	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CFAP47 DNAH7 MYO5C LRRC9 FREM2 PKHD1	2.38e-05	165	154	6	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CFAP47 DNAH7 MYO5C LRRC9 FREM2 PKHD1	2.38e-05	165	154	6	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 FSIP2 DNAH17 PKHD1 AKT2	2.82e-05	170	154	6	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZCCHC18 ZCCHC12 EML6 ZNF2 TUBB4A DNAH17	3.21e-05	174	154	6	742c73c9e090848b464323cb17579b86658c6792
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH1 MYH4 ABCA10 BCO1 PLCG2 SEC14L5	3.21e-05	174	154	6	3503c7dec498597f76a86dbd5e4bb2311e743bde
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZCCHC18 ZCCHC12 EML6 ZNF2 TUBB4A DNAH17	3.21e-05	174	154	6	7fed9722e64c60843092f2ba71256e3043011ef6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 EML6 ALDH1A2 DNAH17 PKHD1	3.42e-05	176	154	6	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAOB PCDHB12 TGM2 PIEZO2 DST SEC14L5	3.53e-05	177	154	6	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 EML6 ALDH1A2 DNAH17 PKHD1	3.53e-05	177	154	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAOB PCDHB12 TGM2 PIEZO2 DST SEC14L5	3.53e-05	177	154	6	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS12 TUBB6 TGM2 ALDH1A2 PIEZO2 PLXNB3	3.53e-05	177	154	6	b1775e05c28883a15c56628028770bc59d3233fb
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAOB DIS3L IDE MYO5C FMNL3 AKT2	4.00e-05	181	154	6	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	Children_(3_yrs)-Immune-enucleated_erythrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBXW12 SLC30A1 KCTD17 MSH6 PCIF1 TRMT5	4.00e-05	181	154	6	c029cecbd7182c70b9893d8c86f334c16291a0db
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4\|TCGA-Thymus / Sample_Type by Project: Shred V9	MYH1 MYH2 MYH4 BCO1 NLRP13	4.03e-05	110	154	5	56e93e8d0d6232ab9090f685e5e4803ef79b2567
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB12 ARHGAP39 PEX5L IL1RAPL1 ALDH1A2 PLXNB3	4.13e-05	182	154	6	a512863304fad80acaab60a8c6107eb7c9cbac99
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKAP6 TUBB4A PNMA2 MED12L SVOP UNC13A	4.13e-05	182	154	6	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RABEP2 PIKFYVE DUS2 TUBB6 PLCG2 GEN1	4.13e-05	182	154	6	9c120ddd109103ef6fac9c32b84d16a7624d0580
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 ALDH1A2 DNAH17 PKHD1 AKT2	4.25e-05	183	154	6	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 ABCA13 FREM2 PIEZO2 LOXHD1 PKHD1	4.39e-05	184	154	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 ABCA13 FREM2 PIEZO2 LOXHD1 PKHD1	4.39e-05	184	154	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 ABCA13 FREM2 PIEZO2 LOXHD1 PKHD1	4.39e-05	184	154	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZCCHC12 ETV4 PEX5L ALDH1A2 GPR158 PNMA2	4.52e-05	185	154	6	30263c558ee331e0879abcf8b4c2427ff05f9fe7
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP39 PEX5L IL1RAPL1 FREM2 LRRN3 PNMA2	4.52e-05	185	154	6	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZCCHC12 ETV4 PEX5L ALDH1A2 GPR158 PNMA2	4.52e-05	185	154	6	1b000ca11970db8f347eb97ff44605d562aea70a
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CCDC192 MYH2 MYO5C PNMA5 TRPV6	4.59e-05	113	154	5	6f270b7e59c18243e876311df721e948ce21e850
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 DNAH7 PKHD1 PLCB1 AKT2	4.66e-05	186	154	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 DNAH7 PKHD1 PLCB1 AKT2	4.80e-05	187	154	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-9\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	PPP4R1 RRAS2 DUS2 TUBB6 GSDME PYGL	4.80e-05	187	154	6	f002ff1a7cb7577f28acff008bc2aa561ac1a4bf
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RRAS2 NSF BPIFB1 RILPL1 PLXNB3 PSMG4	4.80e-05	187	154	6	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 DNAH7 PKHD1 PLCB1 AKT2	4.94e-05	188	154	6	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 EML6 DNAH7 ALDH1A2 PKHD1	5.09e-05	189	154	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A EML6 ALDH1A2 KIAA1217 PKHD1 PLCB1	5.09e-05	189	154	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 DNAH7 ALDH1A2 PKHD1 PLCB1	5.24e-05	190	154	6	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	OLFML3 ADAMTS12 CITED2 IL1RAPL1 ALDH1A2 PIEZO2	5.40e-05	191	154	6	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MAOB ADAMTS12 TGM2 LRRN3 PIEZO2 DST	5.55e-05	192	154	6	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATRX BCL9 PCNX1 LRRC8B AQR PUS7L	5.72e-05	193	154	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A SH2D3A DNAH7 AOPEP PKHD1 PLCB1	5.72e-05	193	154	6	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A SH2D3A DNAH7 AOPEP PKHD1 PLCB1	5.72e-05	193	154	6	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 DNAH7 AOPEP PKHD1 PLCB1	5.88e-05	194	154	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PPP4R1 NSF TUBB6 AKT2 PLCG2 GEN1	5.88e-05	194	154	6	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	OLFML3 ADAMTS12 CITED2 IL1RAPL1 ALDH1A2 PIEZO2	5.88e-05	194	154	6	a3e5a15cf6c1361207f661ee15eb634f77daf1cb
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA10 OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.05e-05	195	154	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	MAOB ABCA10 ADAMTS12 TGM2 PIEZO2 DST	6.05e-05	195	154	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA10 OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.05e-05	195	154	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC16A9 PEX5L IL1RAPL1 PIEZO2 LRRC8B SEC14L5	6.23e-05	196	154	6	efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA10 OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.23e-05	196	154	6	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAOB ABCA10 OLFML3 ADAMTS12 PIEZO2 DST	6.23e-05	196	154	6	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SH2D3A MYO5C AOPEP CSAD PKHD1 DDX43	6.40e-05	197	154	6	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PEX5L FMNL2 TUBB4A PIEZO2 DST SEC14L5	6.40e-05	197	154	6	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAOB OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.40e-05	197	154	6	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAOB ABCA10 OLFML3 ADAMTS12 PIEZO2 DST	6.59e-05	198	154	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAOB OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.59e-05	198	154	6	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OLFML3 ADAMTS12 TGM2 LRRN3 PIEZO2 DST	6.77e-05	199	154	6	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OLFML3 ADAMTS12 TGM2 LRRN3 PIEZO2 DST	6.77e-05	199	154	6	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OLFML3 ADAMTS12 TGM2 LRRN3 PIEZO2 DST	6.77e-05	199	154	6	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PEX5L FMNL2 TUBB4A PIEZO2 DST SEC14L5	6.77e-05	199	154	6	214a6a267e77e5508867b9eb48c4fbc7855ed0a0
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAOB OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.77e-05	199	154	6	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	MAOB OLFML3 ADAMTS12 TGM2 PIEZO2 DST	6.77e-05	199	154	6	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MAOB OLFML3 ADAMTS12 TGM2 PIEZO2 DST	6.77e-05	199	154	6	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAOB ABCA10 ADAMTS12 TGM2 PIEZO2 DST	6.96e-05	200	154	6	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MAOB OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.96e-05	200	154	6	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO9A SH2D3A ECE1 MYO5C CSAD PKHD1	6.96e-05	200	154	6	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MAOB OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.96e-05	200	154	6	a510deaada669e690329183e18df02870bd204b3
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC\|Multiple_Sclerosis / Disease, condition lineage and cell class	GPRASP1 EML6 DUS2 PNMA5 AOPEP MAN1B1	6.96e-05	200	154	6	ab9bdc9365cbdffe4ed246ce0c8a008a390e387e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAOB ADAMTS12 TGM2 ALDH1A2 DST SRPX	6.96e-05	200	154	6	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAOB ADAMTS12 TGM2 ALDH1A2 DST SRPX	6.96e-05	200	154	6	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MAOB ABCA10 OLFML3 ADAMTS12 PIEZO2 DST	6.96e-05	200	154	6	6461d25fd8fb52921b188f083fbe808535d3130b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAOB OLFML3 ADAMTS12 LRRN3 PIEZO2 DST	6.96e-05	200	154	6	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 ESPNL PKHD1	7.60e-05	65	154	4	b7bc23af54d6d2f7afd584f4df42c24d7c49e344
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 ESPNL PKHD1	7.60e-05	65	154	4	3b3630253f5713c4a688c74c4ea0f98c1fe42594
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ESPNL RILPL1 BCO1 PNMA5 PKHD1	7.70e-05	126	154	5	7dcc79bf35482e8e5e5a1de7279ba080edb70522
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	CASP8 BTAF1 PKHD1 PCNX1 PLCG2	1.07e-04	135	154	5	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	(01)_Cycling_Basal_(homeostasis)-(1)_24hpi\|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint	MAOB EML6 ESPNL PKHD1	1.07e-04	71	154	4	6aa56b0daaeb5e0ae30619f9c6945c8e42899b27
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH1 MYH4 ABCA13 AGPS PKHD1	1.10e-04	136	154	5	82b1d6d839c0d0c68e0960549f688138479defcc
ToppCell	PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CFAP47 PAK6 LRRC9 PKHD1 TRPV6	1.27e-04	140	154	5	8abbd5dc799943b49cd0045d0da405c3f3d0db6b
ToppCell	PCW_05-06-Epithelial-Epithelial_ciliated\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CFAP47 PAK6 LRRC9 PKHD1 TRPV6	1.27e-04	140	154	5	e4689232c473d239b07a7fbcaaa3414fbd9badea
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 ALDH1A2 PKHD1 AKT2	1.40e-04	143	154	5	7a7a9829ba63468c9745904d9e993590051207ab
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)\|Thalamus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 MYH4 CATSPERG	1.47e-04	77	154	4	7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML6 LRRC9 ADAMTS12 TUBB4A NEURL4	1.86e-04	152	154	5	acfafdb64bd5b0eb7371b04cfef51ed2798e9b30
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML6 LRRC9 ADAMTS12 TUBB4A NEURL4	1.86e-04	152	154	5	9d6c88ceca0569dbeb12e488acec7fcb7f972f03
Drug	eye gene	MYH1 MYH2 MYH4 MAOB MYO9A TRPC1 MYO5C BCO1 ACTL8 PLCB1 PYGL AKT1 PLCG2	1.34e-06	369	153	13	CID000004782
Drug	AC1L1IZ2	MYH1 MYH2 MYH4 TRPM7 MYO9A AGPS MYO5C TUBB6 TUBB4A ACTL8 AKT2	6.98e-06	304	153	11	CID000004795
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A	CASP8 ECE1 C2orf68 SCAF4 ACTL8 PLCB1 TRPV6 AKT2 ZMYM6	7.11e-06	195	153	9	6067_DN
Drug	NSC339663	MYH1 MYH2 MYH4 MYO9A MYO5C PIKFYVE TUBB6 TUBB4A ACTL8 AKT1	7.73e-06	250	153	10	CID000003892
Drug	CHEMBL459685	CASP8 PIKFYVE AKT1 AKT2 PLCG2	8.93e-06	42	153	5	CID010995375
Drug	4-chloroaniline	MYH1 MYH2 MYH4 COX11 PAK6 ACTL8 PNMA2 TRPV6 AKT1	9.44e-06	202	153	9	CID000007812
Drug	blebbistatin	MYH1 MYH2 MYH4 MYO9A MYO5C ACTL8 AKT1	1.36e-05	116	153	7	CID003476986
Drug	B0683	MYH1 MYH2 MYH4 MYO9A MYO5C ACTL8 GLUD1	1.44e-05	117	153	7	CID006398969
Drug	ET-18-OCH3	TRPM7 AGPS GSDME PLCB1 TRPV6 AKT1 PLCG2	1.70e-05	120	153	7	CID000001392
Drug	Arbutin	ABCA13 CASP8 ECE1 DNAH7 ABCA10 KCTD17 FMNL3 SF3B1 PKHD1 AKT1	2.26e-05	283	153	10	ctd:D001104
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYO9A MYO5C	2.35e-05	51	153	5	CID000122274
Drug	AC1LADJ6	MYH1 MYH2 MYH4 ETV4 DUS2 ACTL8 GLUD1	2.86e-05	130	153	7	CID000486032
Disease	Neoplasm of uncertain or unknown behavior of ovary	RRAS2 MSH6 AKT1 AKT2	1.31e-05	29	148	4	C0496920
Disease	Hematopoetic Myelodysplasia	SAMD9 ATRX SF3B1 PLCB1	1.31e-05	29	148	4	C2713368
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4	1.45e-05	10	148	3	DOID:0080326 (implicated_via_orthology)
Disease	Ovarian Carcinoma	RRAS2 MSH6 AKT1 AKT2	1.50e-05	30	148	4	C0029925
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4	2.63e-05	12	148	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4	2.63e-05	12	148	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4	3.41e-05	13	148	3	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4	5.38e-05	15	148	3	DOID:0050646 (implicated_via_orthology)
Disease	Colorectal Carcinoma	AKAP6 TRPM7 ABCA13 APC CASP8 PAK6 PEX5L ABCA10 TGM2 MSH6 SACS PKHD1 AKT1	5.65e-05	702	148	13	C0009402
Disease	Adenocarcinoma of large intestine	APC MSH6 TBK1 AKT1 AKT2	1.26e-04	96	148	5	C1319315
Disease	malignant astrocytoma (is_marker_for)	ATRX AKT1 AKT2	2.03e-04	23	148	3	DOID:3069 (is_marker_for)
Disease	adverse effect, response to xenobiotic stimulus	CENPC SCAF4 FMNL3 PLCB1	2.23e-04	59	148	4	EFO_0009658, GO_0009410
Disease	lactic acidosis (implicated_via_orthology)	PYGL TRMT5	2.47e-04	5	148	2	DOID:3650 (implicated_via_orthology)
Disease	Turcot syndrome (disorder)	APC MSH6	2.47e-04	5	148	2	C0265325
Disease	suicide ideation measurement	AOPEP PLCB1	2.47e-04	5	148	2	EFO_0007619
Disease	Malignant neoplasm of breast	AKAP6 MYH1 SH2D3A ARFGEF2 ETV4 CASP8 TGM2 MSH6 MTR PLCB1 UTP20 AKT1 AKT2 LONRF3 GEN1	3.41e-04	1074	148	15	C0006142
Disease	MYELODYSPLASTIC SYNDROME	SAMD9 ATRX SF3B1 PLCB1	3.64e-04	67	148	4	C3463824
Disease	heart septal defect	WDR7 YTHDC2	3.70e-04	6	148	2	MONDO_0002078
Disease	Malignant Neoplasms	APC CITED2 SF3B1 AKT1 AKT2	4.78e-04	128	148	5	C0006826
Disease	ovarian neoplasm	RRAS2 BCL9 MSH6 AKT1 AKT2	5.89e-04	134	148	5	C0919267
Disease	Malignant neoplasm of ovary	RRAS2 BCL9 MSH6 AKT1 AKT2	6.52e-04	137	148	5	C1140680
Disease	hypoglycemia (is_implicated_in)	GLUD1 AKT2	6.86e-04	8	148	2	DOID:9993 (is_implicated_in)
Disease	ovarian cancer (implicated_via_orthology)	APC MSH6	6.86e-04	8	148	2	DOID:2394 (implicated_via_orthology)
Disease	Bipolar Disorder	MAOB ABCA13 CASP8 BCL9 TGM2 MTR PLCB1 AKT1 AKT2	7.07e-04	477	148	9	C0005586
Disease	endometrial cancer (is_implicated_in)	APC MSH6 AKT2	7.82e-04	36	148	3	DOID:1380 (is_implicated_in)
Disease	osteoarthritis, hand	MYH2 SUPT3H ALDH1A2	8.48e-04	37	148	3	EFO_1000789
Disease	HEPATOCELLULAR CARCINOMA	APC CASP8	8.79e-04	9	148	2	114550
Disease	Lynch Syndrome	APC MSH6	8.79e-04	9	148	2	C4552100
Disease	Hepatocellular carcinoma	APC CASP8	8.79e-04	9	148	2	cv:C2239176
Disease	cholesterol in very small VLDL measurement	ABCA10 ALDH1A2 PCIF1	1.07e-03	40	148	3	EFO_0022231
Disease	ptosis (implicated_via_orthology)	TUBB6 TUBB4A	1.10e-03	10	148	2	DOID:0060260 (implicated_via_orthology)
Disease	tubulinopathy (implicated_via_orthology)	TUBB6 TUBB4A	1.10e-03	10	148	2	DOID:0112227 (implicated_via_orthology)
Disease	facial paralysis (implicated_via_orthology)	TUBB6 TUBB4A	1.10e-03	10	148	2	DOID:13934 (implicated_via_orthology)
Disease	complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology)	TUBB6 TUBB4A	1.10e-03	10	148	2	DOID:0090132 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of breast	CASP8 AKT1 AKT2	1.15e-03	41	148	3	C0496956
Disease	Breast adenocarcinoma	CASP8 AKT1 AKT2	1.15e-03	41	148	3	C0858252
Disease	oral microbiome measurement	NRDC APPL2 KIAA1217	1.23e-03	42	148	3	EFO_0801229
Disease	polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement	PEX5L LOXHD1	1.33e-03	11	148	2	EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Disease	cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology)	TUBB6 TUBB4A	1.60e-03	12	148	2	DOID:0050997 (implicated_via_orthology)
Disease	mismatch repair cancer syndrome (is_implicated_in)	MSH6 RNASET2	1.60e-03	12	148	2	DOID:0112182 (is_implicated_in)
Disease	Pancreatic Neoplasm	ATRX APC TGM2 AKT2	1.64e-03	100	148	4	C0030297
Disease	free cholesterol in very small VLDL measurement	ABCA10 ALDH1A2 PCIF1	1.71e-03	47	148	3	EFO_0022275
Disease	Malignant neoplasm of pancreas	ATRX APC TGM2 AKT2	1.76e-03	102	148	4	C0346647
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4	1.81e-03	48	148	3	DOID:423 (implicated_via_orthology)
Disease	Benign tumor of pancreas	APC AKT2	1.88e-03	13	148	2	C0347284
Disease	Intellectual Disability	AKAP6 NSF APC SACS RNASET2 MED12L ZMYM6 MAN1B1	1.94e-03	447	148	8	C3714756
Disease	type 2 diabetes mellitus (implicated_via_orthology)	IDE MTR AKT1 AKT2	1.96e-03	105	148	4	DOID:9352 (implicated_via_orthology)
Disease	lysophosphatidylcholine 15:0 measurement	ALDH1A2 PKHD1	2.19e-03	14	148	2	EFO_0020941
Disease	phospholipids in IDL measurement	ABCA10 ALDH1A2 PCIF1	2.28e-03	52	148	3	EFO_0022164
Disease	cholesterol in small VLDL measurement	ABCA10 ALDH1A2 PCIF1	2.41e-03	53	148	3	EFO_0022228
Disease	pancreatic cancer (is_implicated_in)	APC CASP8 MTR AKT1	2.48e-03	112	148	4	DOID:1793 (is_implicated_in)
Disease	Muscular Atrophy	CITED2 AKT1	2.51e-03	15	148	2	C0026846
Disease	Replication Error Phenotype	MSH6 XPO5	2.51e-03	15	148	2	C1721098
Disease	Microsatellite Instability	MSH6 XPO5	2.51e-03	15	148	2	C0920269
Disease	Yu-Zhi constitution type	FREM2 PIEZO2	2.51e-03	15	148	2	EFO_0007638
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	ALDH1A2 PCIF1	2.51e-03	15	148	2	EFO_0022328
Disease	Neurogenic Muscular Atrophy	CITED2 AKT1	2.51e-03	15	148	2	C0270948
Disease	hepcidin:transferrin saturation ratio	EML6 KCTD17	2.51e-03	15	148	2	EFO_0007902
Disease	Colorectal Neoplasms	TRPM7 ABCA13 APC CASP8 ABCA10 AKT1	2.81e-03	277	148	6	C0009404
Disease	triglycerides in very large VLDL measurement	EXOC6 ALDH1A2 PCIF1	2.82e-03	56	148	3	EFO_0022325
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKHD1 AKT1	2.86e-03	16	148	2	DOID:0110861 (implicated_via_orthology)
Disease	Polyposis, Adenomatous Intestinal	APC AKT1	2.86e-03	16	148	2	C2713442
Disease	Familial Intestinal Polyposis	APC AKT1	2.86e-03	16	148	2	C2713443
Disease	executive function measurement	NSF ARFGEF2 PAK6 ERLIN1 MYO5C PIEZO2 XPO5	2.97e-03	376	148	7	EFO_0009332
Disease	low density lipoprotein particle size measurement	SLC16A9 ALDH1A2 PCIF1	3.12e-03	58	148	3	EFO_0008593
Disease	gout	TRIM46 SLC16A9 ALDH1A2 DST GLUD1	3.16e-03	196	148	5	EFO_0004274
Disease	cortical surface area measurement	RABEP2 EXOC6 RRAS2 SUPT3H SAMD9 NSF APC ARHGAP39 FMNL2 DNAH7 ALDH1A2 SF3B1 AOPEP XRN1 PKHD1	3.19e-03	1345	148	15	EFO_0010736
Disease	Adenomatous Polyposis Coli	APC AKT1	3.23e-03	17	148	2	C0032580
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	ALDH1A2 PCIF1	3.23e-03	17	148	2	EFO_0022232
Disease	Prostatic Neoplasms	CDK2AP2 SAMD9 APC ETV4 PAK6 ALDH1A2 SF3B1 APPL2 AKT1	4.01e-03	616	148	9	C0033578
Disease	Malignant neoplasm of prostate	CDK2AP2 SAMD9 APC ETV4 PAK6 ALDH1A2 SF3B1 APPL2 AKT1	4.01e-03	616	148	9	C0376358
Disease	Pancreatic carcinoma	APC AKT2	4.04e-03	19	148	2	C0235974
Disease	esterified cholesterol measurement, high density lipoprotein cholesterol measurement	ALDH1A2 PCIF1	4.04e-03	19	148	2	EFO_0004612, EFO_0008589
Disease	susceptibility to hepatitis B infection measurement	EML6 ARFGEF2 YTHDC2	4.12e-03	64	148	3	EFO_0008405
Disease	prostate adenocarcinoma (is_implicated_in)	AKT1 AKT2	4.47e-03	20	148	2	DOID:2526 (is_implicated_in)
Disease	Fetal Growth Retardation	SAMD9 GLUD1	4.47e-03	20	148	2	C0015934
Disease	obesity (implicated_via_orthology)	ETV4 ALDH1A2 MED12L PLCB1 PLXNB3	4.67e-03	215	148	5	DOID:9970 (implicated_via_orthology)
Disease	total lipids in large VLDL	EXOC6 ALDH1A2 PCIF1	4.68e-03	67	148	3	EFO_0022175
Disease	schizophrenia (implicated_via_orthology)	LRRN3 PLCB1 AKT1	4.88e-03	68	148	3	DOID:5419 (implicated_via_orthology)
Disease	BREAST CANCER	CASP8 AKT1	4.93e-03	21	148	2	114480
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	ALDH1A2 PCIF1	4.93e-03	21	148	2	EFO_0022277
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	ALDH1A2 PCIF1	4.93e-03	21	148	2	EFO_0022246

Protein segments in the cluster

Peptide	Gene	Start	Entry
MKIRERNKPEIFELI	UNC13A	631	Q9UPW8
KLFELILMEEIRFPR	AKT1	356	P31749
ERLFELILMEEIRFP	AKT2	356	P31751
EFIPEARGLEFLMIL	CATSPERG	451	Q6ZRH7
IEFPILKLNGRTMEI	ERI3	166	O43414
DILEEIIRQMKVFHP	NT5C3B	161	Q969T7
QELLVKIPLDMVAGF	BPIFB1	106	Q8TDL5
PKEVEQEVKRIIMEL	ABCA10	501	Q8WWZ4
REPADRKKMLEILFE	ACTL8	106	Q9H568
MRIAKEEIFGPVQEI	ALDH1A2	411	O94788
KIPEAIRRNFELMEA	ERLIN1	176	O75477
AVLFDDELLMVLEPV	GSDME	316	O60443
EIMQFDLIPELRAVL	ARFGEF2	1741	Q9Y6D5
PEIRKEVFELLEMGV	CMSS1	251	Q9BQ75
NMFINLPRVKELLED	ABCA13	3261	Q86UQ4
ERFIELMIDLEALLP	AQR	251	O60306
FLQMLLENIPEEKRL	AOPEP	626	Q8N6M6
PMREALKLRIQEEIA	C2orf68	146	Q2NKX9
FDVMFKLEVPRIQLE	CGAS	226	Q8N884
LEMPLSIFVEAEEKR	CCER1	361	Q8TC90
LIPKGARDIRVMEIE	ADAMTS12	721	P58397
GMEFKLIEPEEVARL	ETV4	366	P43268
KLREIVLPMEKEIEE	RABEP2	151	Q9H5N1
ERMLIKVADREPSFL	ARHGAP39	211	Q9C0H5
LMEELVNFIERVPKA	INTS9	136	Q9NV88
KMLPLLEVAEKEREA	OLFML3	61	Q9NRN5
DLKFDDEVIKMEPRI	LRRC9	656	Q6ZRR7
LLLIAEVMGEDIPEK	C8orf76	311	Q96K31
IMDLLGDRVKLERPV	MAOB	221	P27338
VKEEEFIMPLISIIG	SLC16A9	336	Q7RTY1
PDLASLRKERIIMLF	ESPNL	731	Q6ZVH7
KVSPVLRDFLERMLV	PAK6	626	Q9NQU5
LDVLEKIRPMDDDLL	MED12L	256	Q86YW9
KLEAVDLMEPRLICV	L3MBTL2	541	Q969R5
LVPEFRGVMKVDINL	GPR158	296	Q5T848
IIAMLEREKALRPEV	DST	366	Q03001
ALEGIEKFELVLRMP	FREM2	2091	Q5SZK8
EILDIAPFTKMRIRI	LOXHD1	1606	Q8IVV2
DLERPLELRVKVMDI	DSG4	136	Q86SJ6
ISFLFLEPMEEKLVV	FETUB	341	Q9UGM5
FGREIVEMLLEKLQL	FSIP2	2916	Q5CZC0
MEIRLPDLALKRIFS	FBXW12	1	Q6X9E4
FADMELLRKVVVPGI	PCNX1	1841	Q96RV3
LLREDVEFQPLTLMV	PLXNB3	1506	Q9ULL4
LRLIYNIVEEEPLML	FAT2	2201	Q9NYQ8
EERFALEILPDMLEK	IL1RAPL1	426	Q9NZN1
LIEKPMGIFSILEEE	MYH2	526	Q9UKX2
GLPTEERIQKLEFML	PDZD8	1026	Q8NEN9
RLKEGDLPVTILFME	PEX5L	336	Q8IYB4
EALLRPGRLEVKMEI	NSF	381	P46459
LIEKPMGIFSILEEE	MYH1	526	P12882
PPSFLELMKVIREEE	PNMA2	321	Q9UL42
IEGFLDIMEIKEIRP	PLCG2	61	P16885
RLDAIEDLMVVPDKI	MSH6	791	P52701
NIGPLIRIIKDRMEE	KCTD17	116	Q8N5Z5
MIENLPKLREDIKEI	EXOC6	181	Q8TAG9
EMEVLSLELIPEVKL	LRRC8B	441	Q6P9F7
LAFRLEEEQKMRPEI	MAN1B1	111	Q9UKM7
PVFLEKEMLLEIPEN	PCDHB12	131	Q9Y5F1
DDRFILKQMPRLEVQ	PIKFYVE	1871	Q9Y2I7
DPENRIAKKMLLEEI	ATRX	1266	P46100
DLLSVIEEMGKEIRP	CDK2AP2	76	O75956
EIMNDIPIRLSRIKF	PCIF1	266	Q9H4Z3
VLPFLLRRMKEDVLQ	BTAF1	1496	O14981
MKKELNPVELDFLLR	DNAH17	3741	Q9UFH2
RVKDPETREIILMDL	CENPC	826	Q03188
PEADKIFLERNIMVI	GLUD1	411	P00367
PEFAEDPRMIKVDLI	COX11	241	Q9Y6N1
EILEFPELKGIIFMQ	DIS3L	71	Q8TF46
LMRFLPTEAEVKLLR	FMNL3	681	Q8IVF7
LRDIQRMLFPDEKEF	BCL9	366	O00512
DKVIPMLQEFIINRL	DNAH7	3391	Q8WXX0
MVLPIIQFREKDLTE	APPL2	111	Q8NEU8
EPIKDALMLFQRLQE	CASP8	36	Q14790
APVFVLMEEEVLRKL	CSAD	121	Q9Y600
LMRFLPTENEVKVLR	FMNL2	736	Q96PY5
PDLLLFQRFTLEKME	GEN1	351	Q17RS7
LEEFRPDLIEMVLDK	IDE	456	P14735
FEVIVRERDKPMLIL	EML6	306	Q6ZMW3
IEELRAKPLMELIER	ECE1	191	P42892
IFLKEGLRPLEEVMQ	DUS2	251	Q9NX74
PVEEGDRKISLIMEL	CCDC192	211	P0DO97
GVFKIEIIQPLLDMA	SCAF4	121	O95104
PGVKALLRMIEVVED	SEC14L5	396	O43304
QEIEAELRDPLMIFV	SACS	2066	Q9NZJ4
ELRDPLMIFVLNEKV	SACS	2071	Q9NZJ4
RDMQLRVIPAEVKFL	CFAP47	36	Q6ZTR5
FEPQIMKILLDVRPD	DDX43	406	Q9NXZ2
PLRDNEMFEIRIDKL	NEURL4	356	Q96JN8
TKRLLLPLFREVDMV	NTMT1	76	Q9BV86
FEELLLLMEKIRDPF	GPRASP1	1156	Q5JY77
FQLIEEVPMIKDISL	RTP3	131	Q9BQQ7
EEVVRVPLAFAMVKL	UTP20	1816	O75691
REMKLLTELNFLRVP	TRIM46	416	Q7Z4K8
VIEDPEDKESRLIML	TRMT5	126	Q32P41
MEEDLFQLRQLPVVK	SVOP	1	Q8N4V2
MFPTLEIDIEGQLKR	ADSS1	206	Q8N142
KDITERLILPRFCEM	PPP4R1	206	Q8TF05
EILMIGENPIIRIKD	LRRN3	191	Q9H3W5
MPEFKVRERALLEAL	PUS7L	491	Q9H0K6
EDIMPRGKFLVVFLL	SAMD9	531	Q5K651
ELEDFIMLLEAALPR	HS2ST1	256	Q7LGA3
IFVAKEMERLAIRIP	MTR	841	Q99707
ILRVKDRDEFPMILI	RRAS2	111	P62070
KPVIIIFDEPMDIRS	KIAA1217	1441	Q5T5P2
LIEKPMGIFSILEEE	MYH4	526	Q9Y623
EDLFLNVKPRLDMVE	PKHD1	1011	P08F94
LLVENRIKEEMEAFP	PSMG4	106	Q5JS54
LIDTFPLRKEEMVLQ	SRPX	441	P78539
MEKEFPELIRSVGLL	AKAP6	261	Q13023
LLPGLEERLMKEVEQ	ACTRT1	306	Q8TDG2
VIFLEQPFRLDILKM	BCO1	246	Q9HAY6
LLREGMFERIPDIVL	AGPS	196	O00116
LDEPFIQKDVELRIM	APC	1511	P25054
LVIEMGLDRIKELPE	CITED2	231	Q99967
AEPLQLLLAKVMRFE	CNBD2	121	Q96M20
PNFLELMKLIRDEEE	PNMA5	316	Q96PV4
PVEAGEEVKVRMDLL	TGM2	641	P21980
IMLTEEDPILRAFEL	TRPC1	226	P48995
FNLEEIKDLLPEMRA	RNASET2	81	O00584
VDVRVDGLMLKFVIP	UHRF1BP1L	571	A0JNW5
LEEKNRMLQEDPVLF	GTF2H1	111	P32780
LVPIQRDLYKEVMLE	ZNF2	31	Q9BSG1
RVITPEDLLFLMRKD	SUPT3H	76	O75486
ARLMPKVVRVLEILE	RILPL1	51	Q5EBL4
LISKIREEFPDRIMN	TUBB6	151	Q9BUF5
EAALAFEQELKPLMR	SH2D3A	441	Q9BRG2
LILIREFQSPDEEMK	SF3B1	771	O75533
LISKIREEFPDRIMN	TUBB4A	151	P04350
IMFEELPNVDRILKL	PIEZO2	2696	Q9H5I5
LPLLLVDEMEEKDIL	USP25	966	Q9UHP3
IPFIDEKRLLEAMET	XRN1	566	Q8IZH2
LEDRKPLMVLFGDVA	XPO5	281	Q9HAV4
AIIILLVEVPDIFRM	TRPV6	436	Q9H1D0
MLQKLGPEKRIFEEI	NRDC	531	O43847
RILEKLKPLMDVDEE	PSME4	1536	Q14997
RLPLEILEFVQEAMK	PLCB1	1156	Q9NQ66
VRLVKLPFFNMLDEL	PIAS4	131	Q8N2W9
VIPARLLKMEVRAEE	nan	36	A8MV72
RPFEVKEMFLEDILR	YTHDC2	371	Q9H6S0
RDVKEELLFCIEMPT	ZMYM6	936	O95789
LPNFLELIKMIREEE	ZCCHC18	206	P0CG32
IMFEELPCVDRILKL	PIEZO1	2466	Q92508
KLMEPERLNEIVEKF	ZMYM1	1121	Q5SVZ6
ILLEAIERFIEPHEM	SLC30A1	96	Q9Y6M5
LILDFVLKQDMPLVG	TIGD7	51	Q6NT04
AIPELMRIFVDIEKL	PYGL	346	P06737
EILIEKMPTDVVDLL	WDR7	1311	Q9Y4E6
ITEEIPMEVFKEVRI	TRPM7	806	Q96QT4
LRPVDVQMREFEVLK	TBK1	46	Q9UHD2
LPNFLELIRMVREEE	ZCCHC12	206	Q6PEW1
RPEMRTKEQILELLV	ZNF263	71	O14978
GVEQLMFIKEDLILP	FAM50B	231	Q9Y247
VIMEELIAKFLPEEL	LONRF3	521	Q496Y0
IEEFMSQPEKLLFII	NLRP13	296	Q86W25
QPVIDLIEAKMGILE	MYO5C	491	Q9NQX4
EKEELTFEMLVLEPR	MYO9A	2346	B2RTY4